全文获取类型
收费全文 | 14959篇 |
免费 | 1341篇 |
国内免费 | 563篇 |
专业分类
耳鼻咽喉 | 121篇 |
儿科学 | 306篇 |
妇产科学 | 97篇 |
基础医学 | 4137篇 |
口腔科学 | 533篇 |
临床医学 | 965篇 |
内科学 | 3366篇 |
皮肤病学 | 241篇 |
神经病学 | 310篇 |
特种医学 | 214篇 |
外国民族医学 | 1篇 |
外科学 | 826篇 |
综合类 | 1849篇 |
现状与发展 | 8篇 |
预防医学 | 1266篇 |
眼科学 | 94篇 |
药学 | 981篇 |
5篇 | |
中国医学 | 741篇 |
肿瘤学 | 802篇 |
出版年
2024年 | 16篇 |
2023年 | 322篇 |
2022年 | 385篇 |
2021年 | 698篇 |
2020年 | 571篇 |
2019年 | 449篇 |
2018年 | 481篇 |
2017年 | 502篇 |
2016年 | 549篇 |
2015年 | 597篇 |
2014年 | 865篇 |
2013年 | 1115篇 |
2012年 | 780篇 |
2011年 | 857篇 |
2010年 | 717篇 |
2009年 | 731篇 |
2008年 | 683篇 |
2007年 | 720篇 |
2006年 | 648篇 |
2005年 | 582篇 |
2004年 | 572篇 |
2003年 | 442篇 |
2002年 | 405篇 |
2001年 | 363篇 |
2000年 | 297篇 |
1999年 | 258篇 |
1998年 | 232篇 |
1997年 | 219篇 |
1996年 | 165篇 |
1995年 | 177篇 |
1994年 | 165篇 |
1993年 | 148篇 |
1992年 | 121篇 |
1991年 | 114篇 |
1990年 | 100篇 |
1989年 | 111篇 |
1988年 | 99篇 |
1987年 | 74篇 |
1986年 | 65篇 |
1985年 | 80篇 |
1984年 | 56篇 |
1983年 | 38篇 |
1982年 | 63篇 |
1981年 | 41篇 |
1980年 | 51篇 |
1979年 | 36篇 |
1978年 | 28篇 |
1977年 | 21篇 |
1976年 | 31篇 |
1975年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
71.
《Vaccine》2016,34(36):4304-4312
Small-molecule adjuvants that boost and direct adaptive immunity provide a powerful means to increase the effectiveness of vaccines. Through rational design several novel imidazoquinoline and oxoadenine TLR7/8 agonists, each with unique molecular modifications, were synthesized and assessed for their ability to augment adaptive immunity. All agonists bound human TLR7 and TLR8 and induced maturation of both human mDCs and pDCs. All agonists prompted production of type I interferon and/or proinflammatory cytokines, albeit with varying potencies. In most in vitro assays, the oxoadenine class of agonists proved more potent than the imidazoquinolines. Therefore, an optimized oxoadenine TLR7/8 agonist that demonstrated maximal activity in the in vitro assays was further assessed in a vaccine study with the CRM197 antigen in a porcine model. Antigen-specific antibody production was greatly enhanced in a dose dependent manner, with antibody titers increased 800-fold compared to titers from pigs vaccinated with the non-adjuvanted vaccine. Moreover, pigs vaccinated with antigen containing the highest dose of adjuvant promoted a 13-fold increase in the percentage of antigen-specific CD3+/CD8+ T cells over pigs vaccinated with antigen alone. Together this work demonstrates the promise of these novel TLR7/8 agonists as effective human vaccine adjuvants. 相似文献
72.
73.
《Vaccine》2021,39(11):1631-1641
Records of cattle vaccination against paratuberculosis (PTB) have been analyzed to determine whether or not non-specific effect (NSE) on overall mortality similar to that observed in BCG vaccinated humans occurs in animals. The results of a previously reported slaughterhouse study on PTB prevalence were used as a reference on the age incidence of advanced patent (clinical) epidemio-pathogenic forms. In the proper vaccine study, cows in 30 cattle farms in the Basque Country, Spain were followed-up for between 1 and 13 years. Vaccinated groups were composed by 1008 (592 right-censored) animals younger than 3 months treated as calves and by 3761 (3160 right-censored) vaccinated at any older age. Controls were 339 (157 right-censored) and 4592 (2213 right-censored) age matched animals, respectively. Individual last year presence in the annual testing was considered age at culling or death. A survival analysis was carried out according age at vaccination of vaccinated versus non-vaccinated animals. PTB age incidence in the slaughterhouse study was subtracted from the difference between vaccinated and non-vaccinated animals at the same age in order to estimate PTB-specific and non-specific effects. The maximum difference was observed at the 2–3 years interval with a 33.9% mortality reduction in the calf vaccinated group. This corresponded also with the maximum NSE that was 24.5% for a PTB incidence of 9.5%. Overall, vaccination afforded to calves a 26.5% yearly mortality protection, split between 11.1% PTB-specific and 15.4% NSE. These results support a NSE on total mortality associated with PTB vaccination that appeared to persist for up to 6–7 years. This confirms for the first time in an animal field study the innate immune system memory predicted by the recently proposed trained immunity theory. Contrasting the literature, no deleterious effects of killed vaccines on females were observed. Mortality reduction would offset vaccination costs and could improve livestock systems efficiency and potentially reduce antibiotic use.Clinical trial registered with Spanish Agency for Drugs and Sanitary products (AEMPS) as 11/012/ECV. 相似文献
74.
《Immunity》2021,54(12):2772-2783.e5
75.
76.
The discovery of new curative drugs and the consumption of natural dietary ingredients with the ability to exhibit immunomodulatory activity is urgently needed to decrease the risk of chronic diseases among the population. Rosmarinus officinalis (Lamiaceae) is an aromatic plant that has been traditionally and medicinally used as a carminative, antispasmodic, painkiller, circulatory tonic, to stimulate hair growth and to improve memory dysfunction. This study aimed to assess the potential effects of rosemary solvent extracts on human immune function. Science Direct, Web of Science, Wiley, Elsevier, PubMed, Scopus, and the Google scholar search engines were used to retrieve relevant information included combinations of “rosemary” or “R. officinalis” with “immune function,” “immunity,” “immune system,” “anti‐inflammatory,” “inflammation,” or “health benefit.” A number of studies have been found a stimulatory effect of rosemary and its active compounds on the immune system in vitro and animal study, but there is a lack of evidence in humans for supporting this. The results demonstrated the potential of rosemary and its main active components as dietary ingredients with immunomodulatory functionality. Human studies should be performed and a double‐blind randomized controlled trial would be ideal. 相似文献
77.
Yukie Fujimoto Natsuko Inoue Koji Morimoto Takahiro Watanabe Seiichi Hirota Michiko Imamura Yosuke Matsushita Toyomasa Katagiri Haruki Okamura Yasuo Miyoshi 《Cancer science》2020,111(1):209-218
Analysis of anticancer immunity aids in assessing the prognosis of patients with breast cancer. From 250 operated breast cancers, we focused on serum levels of C‐C motif chemokine ligand 5 (CCL5), which is involved in cancer immune reactions. Serum levels of CCL5 were measured using a cytometric bead‐based immunoassay kit and CCL5 expression in cancer cells was determined using immunohistochemical staining. In addition, mRNA in cancer and stromal cells was analyzed by microdissection and comparison with the public dataset. Disease‐free survival (DFS) of patients with high CCL5 levels (cut‐off, 13.87 ng/mL; n = 192) was significantly better than those with low CCL5 levels (n = 58; hazard ratio, 0.20; 95% confidence interval, 0.10‐0.39; P < .0001). An improved overall survival was observed in patients with high CCL5 levels compared to those with low CCL5 levels (P = .024). On the contrary, high immunohistochemical expression of CCL5 in cancer cells was significantly associated with decreased DFS. As serum CCL5 levels did not correlate with CCL5 expression in cancer cells and the relative expression of mRNA CCL5 was elevated in stromal cells in relation to cancer cells, serum CCL5 might be derived not from cancer cells, but from stromal cells. Expression of CCL5 in serum, but not in cancer cells, might contribute to improved patient prognosis mediating through not only immune reaction, but through other mechanisms. Determination of circulating CCL5 levels could be useful for predicting patient prognosis. 相似文献
78.
79.